WallStSmart

Kenvue Inc. (KVUE)vsSolesence, Inc. Common Stock (SLSN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 25220% more annual revenue ($15.29B vs $60.40M). KVUE leads profitability with a 10.6% profit margin vs 1.6%. KVUE trades at a lower P/E of 21.1x. KVUE earns a higher WallStSmart Score of 68/100 (B-).

KVUE

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.22

SLSN

Avoid

24

out of 100

Grade: F

Growth: 4.0Profit: 3.5Value: 4.0Quality: 4.5
Piotroski: 3/9Altman Z: -0.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$9.91

Current Price

$17.71

$7.80 premium

UndervaluedFair: $9.91Overvalued

Intrinsic value data unavailable for SLSN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

SLSN0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

SLSN4 concerns · Avg: 3.0/10
Market CapQuality
$79.11M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Profit MarginProfitability
1.6%3/10

1.6% margin — thin

Debt/EquityHealth
1.313/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : SLSN

SLSN has a balanced fundamental profile.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Bear Case : SLSN

The primary concerns for SLSN are Market Cap, Return on Equity, Profit Margin. A P/E of 112.0x leaves little room for execution misses. Thin 1.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

SLSN carries more volatility with a beta of 1.24 — expect wider price swings.

KVUE is growing revenue faster at 4.5% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (68/100 vs 24/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Solesence, Inc. Common Stock

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company is headquartered in Romeoville, Illinois.

Want to dig deeper into these stocks?